Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cleaning Up The ‘Orange Book’: US FDA Clarifies Market Status Reporting Requirements

Feb 04 2019

• By Sue Sutter

White pills on an orange background. - Image

Related Content

Drug Sponsors Who Fail To Submit One-Time Marketing Report Face Big Penalty

Feb 08 2018

Outlook For Orange Book Update Not Too Rosy

Apr 19 2018

FDA Aims To 'Pierce The Rhetoric' On Generic Application Backlog

Oct 31 2016

Additional Topics

United States Generic Drugs FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window